VšĮ Infekcinių ligų ir patogeninės mikrobiologijos institutas Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
144,953 |
40,603 |
0 |
- |
- |
- |
- |
51,125 |
5,409 |
6,924 |
49,610 |
2023 |
---|
104,192 |
34,731 |
0 |
- |
- |
- |
- |
50,555 |
5,346 |
20,014 |
35,887 |
2024 |
---|
231,183 |
77,061 |
0 |
- |
- |
- |
- |
146,460 |
19,583 |
19,536 |
146,507 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
231,183 €122 % *
Sales per employee (€)
77,061 €122 % *
Profit before tax (€)
0 €- *
Net Profit (€)
-Profit per employee (€)
-Total profitability (%)
-Net profitability (%)
-Equity (€)
146,460 €190 % *
Amounts Payable And Liabilities (€)
19,583 €266 % *
Non-current Assets (€)
19,536 €-2 % *
CurrentAssets (€)
146,507 €308 % *